Shape Memory Medical Receives FDA Clearance for the IMPEDE-FX Embolization Plug

Shape Memory Medical Inc. announced today it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the IMPEDE-FX Embolization Plug. The IMPEDE-FX Embolization Plug is an adjunct to the IMPEDE Embolization Plug which previously received 510(k) clearance by the FDA and is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The IMPEDE-FX is available in three sizes, with the maximum device having an expanded diameter of 12 mm.

Read the full announcement at Business Wire

Shape Memory Medical Names Bart Balkman as Chief Commercial Officer

Shape Memory Medical Inc. announced today that Bart Balkman has joined the Company as its Chief Commercial Officer. Bart most recently served as NuVasive Specialized Orthopedics Vice President of Sales, a position he assumed upon the purchase of Ellipse, where he was Vice President Sales & Marketing. Prior to these roles, Bart had similar senior management roles at Arstasis, CardioKinetix, Concentric Medical, and several other emerging companies. Bart’s career also includes positions at Heart Technology, Medtronic, Edwards, and Johnson and Johnson. Bart earned a BS from Oklahoma State University and attended the Sales Management Executive Program at Columbia University.

Read the full announcement at Business Wire

Shape Memory Medical Receives FDA Clearance for the IMPEDE Embolization Plug

Shape Memory Medical Inc. announced today it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the IMPEDE Embolization Plug. The IMPEDE Embolization Plug is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. It is available in three sizes, to treat vessels up to 10 mm in diameter.

Read the full announcement at Business Wire and also at Lawrence Livermore National Laboratory News

Shape Memory Medical Raises Series B, Led by HBM Healthcare Investments Ltd.

Shape Memory Medical Inc. announced today the initial closing of its Series-B Preferred Stock financing. The round was led by HBM Healthcare Investments Ltd. Current investors, including affiliates of Wexford Capital LP and HBM-MedFocus Funds participated in this financing, and were joined by new investor Emergent Medical Partners.

Read the full announcement at Business Wire

Shape Memory Medical Hires Industry Veteran Ted Ruppel as CEO

Shape Memory Medical (formerly Shape Memory Therapeutics (SMT)) announced today the hiring of medical device industry veteran Ted Ruppel as President & CEO.

Ted Ruppel brings more than 25 years of entrepreneurial and medical device company management experience, including the IPO of Micrus Endovascular Corp.  Formerly EVP/CFO of Vascular Dynamics and the former Senior VP of R&D and Operations at Micrus Endovascular Corporation (acquired by J&J), and previous management/operations roles at CBYON Inc., Biometric Imaging (acquired by BD), Applied Biosystems, and Spectra-Physics Lasers, Ted has a BSME from the University of Rochester and MBA (TRIUM – Jointly conferred by London School of Economics and Political Science, NYU Stern School of Business, and HEC Paris).

Read the full story.